Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
about
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitorsThe PI3K pathway as drug target in human cancerInflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's DiseaseMolecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell DysfunctionInsulin receptor signaling in normal and insulin-resistant statesInvolvement of the IRE1α-XBP1 pathway and XBP1s-dependent transcriptional reprogramming in metabolic diseasesThe p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling.Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRILCytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal musclePIP3 but not PIP2 increases GLUT4 surface expression and glucose metabolism mediated by AKT/PKCζ/λ phosphorylation in 3T3L1 adipocytesInsulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determinationp85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway.Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.TAT-protein blockade during ischemia/reperfusion reveals critical role for p85 PI3K-PTEN interaction in cardiomyocyte injury.Phosphoinositide 3-kinase signaling in retinal rod photoreceptors.The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinChronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in MiceClass IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity.The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.Role of phosphoinositide 3-kinase signaling in autoimmunity.Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2.Class IA phosphatidylinositol 3-kinase in pancreatic β cells controls insulin secretion by multiple mechanismsProtein tyrosine phosphatases: dual-specificity phosphatases in health and disease.Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.Adipose tissue insulin sensitivity and macrophage recruitment: Does PI3K pick the pathway?Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemiaPioglitazone does not improve insulin signaling in mice with GH over-expression.Resistin competes with lipopolysaccharide for binding to toll-like receptor 4Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.Regulation of epithelial-mesenchymal transition in palatal fusion.Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis.Human placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes.BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.
P2860
Q24305218-E1F7523D-10E6-467E-A560-FE07F092711AQ24632283-7CF7272B-5726-47E1-A0D3-F6EB88CD6B39Q26773657-A6D492D1-DEBB-4467-9FF7-317850DC7476Q26800081-3CF98D49-C5DB-4F60-9B05-190EE59AF686Q26823171-66F62B59-A12F-4A5C-A775-E11DC4B88251Q27015015-80F2D671-7055-4245-85A8-7A7AE5D66A27Q27851848-229D89FB-B377-4028-9566-C8DD78303168Q30156937-7CBE7CA1-ADD7-4454-9763-A1F7BDF6516EQ30481572-093E5C04-6D5E-4098-A99D-AECB2C3ABC16Q30856517-8D81C663-CB62-4C55-A10D-42683B81B962Q33559757-243B7D1D-1D89-4C75-90A0-2A43BA1D17F8Q33619529-D9C492E7-CEB0-4298-AD11-7E54E7F0FF2EQ33750663-D24428EF-2A76-48A1-B09F-3F18E884D8DBQ33777732-2AD0DE5D-91F3-4BE8-8CC9-A753ACD7518FQ33865202-E8C8DC20-58E2-48F1-B85D-FD00A0DBBF1BQ34787325-87BC63D8-B80F-4D69-9B42-874562AC16E9Q35131032-FE7F8EAC-989D-47AA-A2D4-22021797A9C6Q35154138-54F65526-D0CC-4189-B335-7298394126DEQ35221193-5AB17946-8612-4ECB-B227-085FEB3DCCB5Q35479152-6B4FA774-B127-4B21-BDB6-672BA50F4D1CQ35562685-2604A6B2-66B9-43EE-BC7D-E6FCD0D8BE4FQ35681147-6F6C16D2-2501-4EBA-83AC-54A62A363689Q35808718-9C125324-B55F-4ECD-BD65-ED6A61509D71Q35856767-61F92A8B-5280-42E5-AB51-6338E88EE30FQ36033370-7C676C9A-EECC-4303-B793-9D438802ED8AQ36150234-3EC79FE1-C2C4-4CA2-9466-CD6032A69CB5Q36922987-AE6D77D5-46A2-4D13-8510-4718DD772D6BQ37008854-F9FBB638-79C9-4775-9304-D606AD72D729Q37078025-F06C69FD-1746-4511-82E5-CA909F07E0FAQ37094068-01F4A906-21B8-4AA2-8312-A96806328E73Q37103052-6B49EA60-0260-4251-A85C-F7C3B4968266Q37129090-5E4EAF4E-9257-41C3-8A42-2E4FF669ACDCQ37201991-1427BA2E-4C3C-4341-80CD-E1558D0B70C7Q37262649-F3065822-CA59-4A47-BACF-133012206B9AQ37310966-373C0F2C-FDF7-4C3E-9F87-9DC62A2A3920Q37351598-5575F43F-0A59-482C-82A2-C656B6E39FE9Q37398452-64FE8874-36C5-475D-B957-97A9E13B06D0Q37418266-02018A38-66D3-446B-9CD9-3DCBCA4DAF7BQ37663399-0A193E0A-471F-43A2-BB50-64C52B3E4909Q37731459-37AB27EF-391D-4BF7-A7F0-8CCCC62A2766
P2860
Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@ast
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@en
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@nl
type
label
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@ast
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@en
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@nl
prefLabel
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@ast
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@en
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@nl
P2093
P2860
P50
P356
P1476
Phosphoinositide 3-kinase regu ...... a positive regulation of PTEN.
@en
P2093
Cullen M Taniguchi
Tatsuya Kondo
Thien T Tran
P2860
P304
12093-12097
P356
10.1073/PNAS.0604628103
P407
P577
2006-07-31T00:00:00Z